Clearmind Medicine Correlations
| CMND Stock | USD 1.13 0.03 2.59% |
The correlation of Clearmind Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Clearmind Medicine Correlation With Market
Average diversification
The correlation between Clearmind Medicine Common and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Clearmind Medicine Common and DJI in the same portfolio, assuming nothing else is changed.
Clearmind | Build AI portfolio with Clearmind Stock |
Moving against Clearmind Stock
| 0.41 | CGEN | Compugen | PairCorr |
| 0.39 | EVGN | Evogene | PairCorr |
| 0.34 | KB | KB Financial Group | PairCorr |
| 0.39 | T | ATT Inc Earnings Call Today | PairCorr |
| 0.38 | IBM | International Business Earnings Call Today | PairCorr |
| 0.36 | DIS | Walt Disney | PairCorr |
Related Correlations Analysis
| 0.72 | -0.03 | 0.73 | -0.1 | DRMA | ||
| 0.72 | -0.3 | 0.49 | 0.13 | JFBR | ||
| -0.03 | -0.3 | 0.06 | -0.61 | SPRC | ||
| 0.73 | 0.49 | 0.06 | -0.31 | VRAX | ||
| -0.1 | 0.13 | -0.61 | -0.31 | ZVSA | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Clearmind Stock performing well and Clearmind Medicine Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Clearmind Medicine's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DRMA | 3.18 | (0.02) | (0.03) | 0.12 | 3.31 | 8.47 | 22.00 | |||
| JFBR | 8.16 | 0.03 | 0.00 | 0.15 | 0.00 | 15.23 | 121.97 | |||
| SPRC | 4.03 | 0.52 | 0.11 | 0.55 | 4.88 | 8.94 | 60.89 | |||
| VRAX | 3.36 | (0.31) | (0.02) | 0.03 | 4.29 | 6.25 | 15.20 | |||
| ZVSA | 6.24 | (2.01) | 0.00 | (5.58) | 0.00 | 9.38 | 67.27 |
Clearmind Medicine Corporate Management
| BCom BComm | CFO Director | Profile | |
| Mylene Touboul | Accounting Manager | Profile | |
| Gilad Babchuk | Head Communication | Profile | |
| Adi Varon | Controller | Profile | |
| Pr Haden | Vice Development | Profile | |
| Pr MSW | Vice Development | Profile | |
| Adi ZuloffShani | Chief Officer | Profile |